Journal of Geriatric Psychiatry and Neurology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Free Access - Register Here

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kazui, H.
Right arrow Articles by Takeda, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kazui, H.
Right arrow Articles by Takeda, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Geriatric Psychiatry and Neurology, Vol. 19, No. 1, 3-12 (2006)
DOI: 10.1177/0891988705277543

Symptoms Underlying Unawareness of Memory Impairment in Patients With Mild Alzheimer’s Disease

Hiroaki Kazui, MD, PhD

Psychiatry and Behavioral Science, Osaka University Graduate School of Medicine, Osaka, Institute for Aging Brain and Cognitive Disorders, Hyogo Brain and Heart Center at Himeji, kazui{at}psy.med.osaka-u.ac.jp

Nobutsugu Hirono, MD, PhD

Institute for Aging Brain and Cognitive Disorders, Hyogo Brain and Heart Center at Himeji, Department of Humanities and Sciences, Kobe Gakuin University, Kobe

Mamoru Hashimoto, MD, PhD

Institute for Aging Brain and Cognitive Disorders, Hyogo Brain and Heart Center at Himeji, Sawa Hospital, Osaka

Yoko Nakano, MD, PhD

Institute for Aging Brain and Cognitive Disorders, Hyogo Brain and Heart Center at Himeji, Departments of Neurology and Gastroentestinology, University of Fukui Faculty of Medical Sciences, Matsuoka-cho

Keiji Matsumoto, MD

Institute for Aging Brain and Cognitive Disorders, Hyogo Brain and Heart Center at Himeji, Department of Neurology, Hyogo Prefectural Amagasaki Hospital, Amagasaki-city

Yohoko Takatsuki

Institute for Aging Brain and Cognitive Disorders, Hyogo Brain and Heart Center at Himeji, Kobe University Graduate School of Medicine Faculty of Health Sciences, Kobe

Etsuro Mori, MD, PhD

Institute for Aging Brain and Cognitive Disorders, Hyogo Brain and Heart Center at Himeji, Division of Neuropsychology/Behavioral Neurology, Department of Disability Science, Tohoku University Graduate School of Medicine, Sendai, Japan

Yoshitaka Ikejiri, MD, PhD

Psychiatry and Behavioral Science, Osaka University Graduate School of Medicine, Osaka

Masatoshi Takeda, MD, PhD

Psychiatry and Behavioral Science, Osaka University Graduate School of Medicine, Osaka

Patients with Alzheimer’s disease (AD) are often unaware of their cognitive impairment. This unawareness might have a multifactorial etiology, including impairment of cognitive domains and psychiatric symptoms. We conducted this study to determine the factors underlying unawareness of memory impairment (UMI) in patients with AD. In 103 patients with mild AD, the UMI was quantified as the difference between the patient’s self-rating and the rating of the patient’s caregiver on a standardized memory questionnaire system, the Everyday Memory Checklist. We then examined the relationships between UMI and memory, attention, language, visuospatial/constructive perception, frontal lobe function, and psychiatric symptoms. UMI was positively associated with memory impairment and delusions when effects of age, sex, and education were partialled out, suggesting that these symptoms are involved in the formation of UMI in the patients. Thus, existing treatments for memory impairment and delusions may be beneficial for increasing the awareness of mild AD patients of their cognitive impairment.

Key Words: unawareness • memory impairment • cognitive impairment • psychiatric symptom • delusion • Alzheimer’s disease

References

  • Feher EP, Mahurin RK, Inbody SB. Anosognosia in Alzheimer’s disease. Neuropsychiatry Neuropsychol Behav Neurol. 1991;4: 136-146.
  • Wagner MT, Spangenberg KB, Bachman DL, O’Connell P. Unawareness of cognitive deficit in Alzheimer’s disease and related dementias. Alzheimer Dis Assoc Disord. 1997;11:125-131.
  • Seltzer B, Vasterling JJ, Yoder JA, Thompson KA. Awareness of deficit in Alzheimer’s disease: relation to caregiver burden. Gerontologist. 1997;37:20-24.[Abstract]
  • Mangone CA, Hier DB, Gorelick PB, et al. Impaired insight in Alzheimer’s disease. J Geriatr Psychiatry Neurol. 1991;4:189-193.
  • Starkstein SE, Sabe L, Chemerinski E, Jason L, Leiguarda R. Two domains of ansognosia in Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 1996;61:485-490.[Abstract]
  • Starkstein SE, Vazquez S, Migliorelli R, Teson A, Sabe L, Leiguarda R. A single-photon emission computed tomographic study of anosognosia in Alzheimer’s disease. Arch Neurol. 1995;52:415-420.[Abstract]
  • Ott BR, Lafleche G, Whelihan WM, Buongiorno GW, Albert MS, Fogel BS. Impaired awareness of deficits in Alzheimer’s disease. Alzheimer Dis Assoc Disord. 1996;10:68-76.[Medline] [Order article via Infotrieve]
  • Michon A, Deweer B, Pillon B, Agid Y, Dubois B. Relation of anosognosia to frontal lobe dysfunction in Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 1994;57:805-809.[Abstract]
  • Lopez OL, Becker JT, Somsak D, Dew MA, DeKosky ST. Awareness of cognitive impairment and anosognosia in probable Alzheimer’s disease. Eur Neurol. 1994;34:277-282.[CrossRef][Medline] [Order article via Infotrieve]
  • Auchus AP, Goldstein FC, Green J, et al. Unawareness of cognitive impairments in Alzheimer’s disease. Neuropsychiatry Neuropsychol Behav Neurol. 1994;7:25-29.
  • Migliorelli R, Petracca G, Teson A, Sabe L, Leiguarda R, Starkstein SE. Neuropsychiatric and neuropsychological correlates of delusions in Alzheimer’s disease. Psychol Med. 1995;25:505-513.[Medline] [Order article via Infotrieve]
  • Derouesne C, Thibault S, Lagha-Pierucci S, et al. Decreased awareness of cognitive impairment in patients with mild dementia of the Alzheimer type. Int J Geriatr Psychiatry. 1999;14:1019-1030.[CrossRef][Medline] [Order article via Infotrieve]
  • Kotler-Cope S, Camp CJ. Anosognosia in Alzheimer’s disease. Alzheimer Dis Assoc Disord. 1995;9:52-56.[Medline] [Order article via Infotrieve]
  • Sevush S, Leve N. Denial of memory deficit in Alzheimer’s disease. Am J Psychiatry. 1993;150:748-751.[Abstract/Free Full Text]
  • Seltzer B, Vaterling JJ, Hale MA, et al. Unawareness of memory deficit in Alzheimer’s disease: relation to mood other disease variables. Neuropsychiatry Neuropsychol Behav Neurol. 1995;8:176-181.
  • Reisberg B, Ferris SH, Anand R, et al. Functional staging of dementia of the Alzheimer type. Ann NY Acad Sci. 1984;435:481-483.
  • Green J, Goldstein FC, Sirockman BE, Green RC. Variable awareness of deficits in Alzheimer’s disease. Neuropsychiatry Neuropsychol Behav Neurol. 1993;3:159-165.
  • Vasterling JJ, Seltzer B, Foss JW, Vanderbrook V. Unawareness of deficit in Alzheimer’s disease. Domain-specific differences and disease correlates. Neuropsychiatry Neuropsychol Behav Neurol. 1995;8:26-32.
  • McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984;34:939-944.[Abstract/Free Full Text]
  • Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566-572.[Abstract/Free Full Text]
  • Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.[CrossRef][Medline] [Order article via Infotrieve]
  • Wilson B, Cockburn J, Baddeley A, Hiorns R. The development and validation of a test battery for detecting and monitoring everyday memory problems. J Clin Exp Neuropsychol. 1989;11:855-870.[Medline] [Order article via Infotrieve]
  • Sunderland A, Harris JE, Baddeley AD. Do laboratory tests predict everuday memory? A neuropsychological study. J Verbal Learning Verbal Behav. 1983;22:341-357.[CrossRef]
  • Kazui H, Watamori TS, Honda R, Mori E. The validation of a Japanese version of the Everyday Memory Checklist [in Japanese]. No To Shinkei. 2003;55:317-325.[Medline] [Order article via Infotrieve]
  • Wechsler DA. WMS-R Manual. New York, NY: Psychological Corporation; 1987.
  • Sugishita M. Manual for the Japanese version of WMS-R. Tokyo, Japan: Nihon Bunka Kagakusha Co, Ltd; 2001.
  • Kertesz A. The Western Aphasia Battery. New York, NY: Grune & Stratton Inc; 1982.
  • Sugishita M. Japanese edition of Western Aphasia Battery. Tokyo, Japan: Igaku-Shoin Ltd; 1986.
  • Sugishita M, Yamazaki K. Japanese Raven’s Colored Progressive Matrices. Tokyo, Japan: Nihon Bunka Kagakusha Co, Ltd; 1993.
  • Yoshimura N, Soma Y, Ootsuki M. Relations between neuropsychological findings and lateral asymmetries of cerebral blood flow measured by SPECT in dementia of Alzheimer type [in Japanese]. Rinsho Shinkeigaku. 1993;33:1029-1032.[Medline] [Order article via Infotrieve]
  • Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308-2314.[Abstract/Free Full Text]
  • Hirono N, Mori E, Ikejiri Y, et al. Japanese version of the Neuropsychiatric Inventory: a scoring system for neuropsychiatric disturbance in dementia patients [in Japanese]. No To Shinkei. 1997;49:266-271.[Medline] [Order article via Infotrieve]
  • Takatuki Y, Hirono N, Yamashita H, et al. Study of language function in Alzheimer patients using Japanese version of Western Aphasia Battery [in Japanese]. Higher Brain Function Research. 1998;18:315-322.[CrossRef]
  • Ikeda M, Shigenobu K, Fukuhara R, et al. Delusions of Japanese patients with Alzheimer’s disease. Int J Geriatr Psychiatry. 2003;18:527-532.[CrossRef][Medline] [Order article via Infotrieve]
  • Sevush S. Relationship between denial of memory deficit and dementia severity in Alzheimer disease. Neuropsychiatry Neuropsychol Behav Neurol. 1999;12:88-94.[Medline] [Order article via Infotrieve]
  • DeBettignies BH, Mahurin RK, Pirozzolo FJ. Insight for impairment in independent living skills in Alzheimer’s disease and multi-infarct dementia. J Clin Exp Neuropsychol. 1990;12:355-363.[Medline] [Order article via Infotrieve]
  • Karlawish JH, Casarett D, Klocinski J, Clark CM. The relationship between caregivers’ global ratings of Alzheimer’s disease patients’ quality of life, disease severity, and the caregiving experience. J Am Geriatr Soc. 2001;49:1066-1070.[CrossRef][Medline] [Order article via Infotrieve]
  • Christensen H, Kopelman MD, Stanhope N, Lorentz L, Owen P. Rates of forgetting in Alzheimer dementia. Neuropsychologia. 1998;36:547-557.[CrossRef][Medline] [Order article via Infotrieve]
  • Derrer DS, Howieson DB, Mueller EA, Camicioli RM, Sexton G, Kaye JA. Memory testing in dementia: how much is enough? J Geriatr Psychiatry Neurol. 2001;14:1-6.[Abstract/Free Full Text]
  • Reed BR, Paller KA, Mungas D. Impaired acquisition and rapid forgetting of patterned visual stimuli in Alzheimer’s disease. J Clin Exp Neuropsychol. 1998;20:738-749.[Medline] [Order article via Infotrieve]
  • Marshall GA, Kaufer DI, Lopez OL, Rao GR, Hamilton RL, DeKosky ST. Right prosubiculum amyloid plaque density correlates with anosognosia in Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2004;75:1396-1400.[Abstract/Free Full Text]
  • Lopez OL, Becker JT, Brenner RP, Rosen J, Bajulaiye OI, Reynolds CF III. Alzheimer’s disease with delusions and hallucinations: neuropsychological and electroencephalographic correlates. Neurology. 1991;41:906-912.[Abstract/Free Full Text]
  • Jeste DV, Wragg RE, Salmon DP, Harris MJ, Thal LJ. Cognitive deficits of patients with Alzheimer’s disease with and without delusions. Am J Psychiatry. 1992;149:184-189.[Abstract/Free Full Text]
  • Starkstein SE, Vazquez S, Petracca G, et al. A SPECT study of delusions in Alzheimer’s disease. Neurology. 1994;44:2055-2059.[Abstract/Free Full Text]
  • Hirono N, Mori E, Ishii K, et al. Alteration of regional cerebral glucose utilization with delusions in Alzheimer’s disease. J Neuropsychiatry Clin Neurosci. 1998;10:433-439.[Abstract/Free Full Text]
  • Sultzer D, Brown C, Mandelkern M, et al. Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer’s disease. Am J Psychiatry. 2003;160:341-349.[Abstract/Free Full Text]
  • Fukuhara R, Ikeda M, Nebu A, et al. Alternation of rCBF in Alzheimer’s disease patients with delusions of theft. Neuroreport. 2001;12:2473-2476.[CrossRef][Medline] [Order article via Infotrieve]
  • Prigatano GP, Schacter DL. Awareness of Deficits After Brain Injury. New York, NY: Oxford University Press; 1991.
  • Constantinidis J, Richard J, Ajuriaguerra J de. Dementias with senile plaques and neurofibrillary tangles. In: Isaacs AD, Post F, eds. Studies in Geriatric Psychiatry. New York, NY: Wiley; 1978:119-152.
  • Rogers SL, Farlow MR, Doody RS. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer’s disease. Neurology. 1998;50:136-145.[Abstract/Free Full Text]
  • Forette F, Anand R, Gharabawi G. A phase II study in patients with Alzheimer’s disease to assess the preliminary efficacy and maximum tolerated dose of rivastigmine (Exelon). Eur J Neurol. 1999;6:423-429.[CrossRef][Medline] [Order article via Infotrieve]
  • Mega MS, Masterman DM, O’Connor SM, Barclay TR, Cummings JL. The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer’s Disease. Arch Neurol. 1999;56:1388-1393.[Abstract/Free Full Text]
  • Rosler M. The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia. Int J Clin Pract Suppl. 2002;127:20-36.
  • Daniel DG. Antipsychotic treatment of psychosis and agitation in the elderly. J Clin Psychiatry. 2000;61(suppl 14):49-52.

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J Geriatr Psychiatry NeurolHome page
J. M. Bruce, R. Bhalla, H. J. Westervelt, J. Davis, V. Williams, and G. Tremont
Neuropsychological Correlates of Self-Reported Depression and Self-Reported Cognition Among Patients With Mild Cognitive Impairment
J Geriatr Psychiatry Neurol, March 1, 2008; 21(1): 34 - 40.
[Abstract] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kazui, H.
Right arrow Articles by Takeda, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kazui, H.
Right arrow Articles by Takeda, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?